‌

US Patent 7811602 Liposomal formulations comprising dihydrosphingomyelin and methods of use thereof

Patent 7811602 was granted and assigned to Tekmira Pharmaceuticals Corporation on October, 2010 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

0

Patent attributes

Current Assignee

Tekmira Pharmaceuticals Corporation

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Barbara L S Mui0

Michael J Hope0

Norbert Maurer0

Pieter R Cullis0

Sean C Semple0

Steven M Ansell0

Thomas D Madden0

Date of Patent

October 12, 2010

0

Patent Application Number

111314360

Date Filed

May 16, 2005

0

Patent Citations Received

US Patent 12129223 Lipids for use in lipid nanoparticle formulations

0

US Patent 11679158 Biodegradable lipids for the delivery of active agents

0

US Patent 11712481 Lipid nanoparticle formulations

0

US Patent 11976019 Cationic lipids for use in lipid nanoparticles

0

US Patent 12065396 Lipids for use in lipid nanoparticle formulations

0

Patent Primary Examiner

Gollamudi S. Kishore

0

Patent abstract

The present invention includes novel liposomes comprising dihydrosphingomyelin. The invention also includes compositions comprising these liposomes and a therapeutic agent, in addition to methods and kits for delivering a therapeutic agent or treating a disease, e.g., a cancer, using these compositions.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7811602 Liposomal formulations comprising dihydrosphingomyelin and methods of use thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool